National Medical Care Company JSC
SAU:4005

Watchlist Manager
National Medical Care Company JSC Logo
National Medical Care Company JSC
SAU:4005
Watchlist
Price: 202.4 SAR 0.8% Market Closed
Market Cap: 9B SAR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+0%
Revenue
Forecast
+14%
Operating Income
Forecast
+22%
Net Income
Forecast
+11%

Wall Street
Price Targets

Price Targets Summary
National Medical Care Company JSC

Wall Street analysts forecast National Medical Care Company JSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for National Medical Care Company JSC is 203.07 SAR with a low forecast of 171.7 SAR and a high forecast of 225.75 SAR.

Lowest Forecast
Wall Street Target
171.7 SAR
15% Downside
Average Forecast
Wall Street Target
203.07 SAR
0% Upside
Highest Forecast
Wall Street Target
225.75 SAR
12% Upside
Lowest
Price Target
171.7 SAR
15% Downside
Average
Price Target
203.07 SAR
0% Upside
Highest
Price Target
225.75 SAR
12% Upside
National Medical Care Company JSC Competitors:
Price Targets
B
BCH
Bangkok Chain Hospital PCL
32% Upside
M12
M1 Kliniken AG
75% Upside
JYNT
Joint Corp
59% Upside
4009
Middle East Healthcare Company SJSC
25% Upside
B
BCH
Bangkok Chain Hospital PCL
32% Upside
M12
M1 Kliniken AG
75% Upside
JYNT
Joint Corp
59% Upside
4009
Middle East Healthcare Company SJSC
25% Upside
4004
Dallah Healthcare Company SJSC
0% Downside
V
VIBHA
Vibhavadi Medical Center PCL
40% Upside
4002
Mouwasat Medical Services Company SJSC
1% Downside
K
KPJ
KPJ Healthcare Bhd
8% Upside

Revenue
Forecast

Revenue Estimate
National Medical Care Company JSC

For the last 8 years the compound annual growth rate for National Medical Care Company JSC's revenue is 5%. The projected CAGR for the next 3 years is 14%.

5%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
National Medical Care Company JSC

For the last 8 years the compound annual growth rate for National Medical Care Company JSC's operating income is 17%. The projected CAGR for the next 3 years is 22%.

17%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
National Medical Care Company JSC

For the last 8 years the compound annual growth rate for National Medical Care Company JSC's net income is 24%. The projected CAGR for the next 3 years is 11%.

24%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is National Medical Care Company JSC's stock price target?
Price Target
203.07 SAR

According to Wall Street analysts, the average 1-year price target for National Medical Care Company JSC is 203.07 SAR with a low forecast of 171.7 SAR and a high forecast of 225.75 SAR.

What is National Medical Care Company JSC's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for National Medical Care Company JSC's revenue is 5%. The projected CAGR for the next 3 years is 14%.

What is National Medical Care Company JSC's Operating Income forecast?
Projected CAGR
22%

For the last 8 years the compound annual growth rate for National Medical Care Company JSC's operating income is 17%. The projected CAGR for the next 3 years is 22%.

What is National Medical Care Company JSC's Net Income forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for National Medical Care Company JSC's net income is 24%. The projected CAGR for the next 3 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.